These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 21094929)
1. Where do we stand in enzyme replacement therapy in Pompe's disease? van der Ploeg AT Neuromuscul Disord; 2010 Dec; 20(12):773-4. PubMed ID: 21094929 [No Abstract] [Full Text] [Related]
2. [Treatment of Pompe's disease with recombinant enzymes]. Van Hove JL Verh K Acad Geneeskd Belg; 1998; 60(4):347-57. PubMed ID: 9883081 [TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation for Pompé's disease. Hoogerbrugge PM; Wagemaker G; van Bekkum DW; Reuser AJ; vd Ploeg AT N Engl J Med; 1986 Jul; 315(1):65-6. PubMed ID: 3086726 [No Abstract] [Full Text] [Related]
7. Glycogen storage disease type II (Pompe's disease): the first biochemical evidence in Thailand. Rangdaeng S; Scollard DM; Srichairatanakol S; Sutthachit M; Phornphutkul C J Med Assoc Thai; 1987 Sep; 70(9):536-42. PubMed ID: 2960768 [No Abstract] [Full Text] [Related]
8. Correction of glycogen storage disease type II by enzyme replacement with a recombinant human acid maltase produced by over-expression in a CHO-DHFR(neg) cell line. Martiniuk F; Chen A; Donnabella V; Arvanitopoulos E; Slonim AE; Raben N; Plotz P; Rom WN Biochem Biophys Res Commun; 2000 Oct; 276(3):917-23. PubMed ID: 11027569 [TBL] [Abstract][Full Text] [Related]
9. Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy. Winkel LP; Kamphoven JH; van den Hout HJ; Severijnen LA; van Doorn PA; Reuser AJ; van der Ploeg AT Muscle Nerve; 2003 Jun; 27(6):743-51. PubMed ID: 12766987 [TBL] [Abstract][Full Text] [Related]
10. Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up. Winkel LP; Van den Hout JM; Kamphoven JH; Disseldorp JA; Remmerswaal M; Arts WF; Loonen MC; Vulto AG; Van Doorn PA; De Jong G; Hop W; Smit GP; Shapira SK; Boer MA; van Diggelen OP; Reuser AJ; Van der Ploeg AT Ann Neurol; 2004 Apr; 55(4):495-502. PubMed ID: 15048888 [TBL] [Abstract][Full Text] [Related]
11. Adeno-associated virus-mediated transfer of human acid maltase gene results in a transient reduction of glycogen accumulation in muscle of Japanese quail with acid maltase deficiency. Lin CY; Ho CH; Hsieh YH; Kikuchi T Gene Ther; 2002 May; 9(9):554-63. PubMed ID: 11973631 [TBL] [Abstract][Full Text] [Related]
12. Effect of enzyme therapy in juvenile patients with Pompe disease: a three-year open-label study. van Capelle CI; van der Beek NA; Hagemans ML; Arts WF; Hop WC; Lee P; Jaeken J; Frohn-Mulder IM; Merkus PJ; Corzo D; Puga AC; Reuser AJ; van der Ploeg AT Neuromuscul Disord; 2010 Dec; 20(12):775-82. PubMed ID: 20817528 [TBL] [Abstract][Full Text] [Related]
13. [Pompe's disease. Part II. Treatment strategies and enzyme replacement]. Illés Z; Várdi Visy K Ideggyogy Sz; 2009 Sep; 62(9-10):299-307. PubMed ID: 19835271 [TBL] [Abstract][Full Text] [Related]
14. Incontinence in late-onset Pompe disease: an underdiagnosed treatable condition. Remiche G; Herbaut AG; Ronchi D; Lamperti C; Magri F; Moggio M; Bresolin N; Comi GP Eur Neurol; 2012; 68(2):75-8. PubMed ID: 22760201 [No Abstract] [Full Text] [Related]
15. More on bone marrow transplantation for glycogen storage disease type II (Pompé's disease). Hug G N Engl J Med; 1986 Nov; 315(19):1229. PubMed ID: 3531866 [No Abstract] [Full Text] [Related]
16. Enzyme Replacement Therapy Provides Effective, Long-Term Treatment of Cardiomyopathy in Pompe Disease. Baba S; Yoshinaga D; Akagi K; Matsuda K; Yokoyama A; Yoshida T; Hirata T Circ J; 2018 Nov; 82(12):3100-3101. PubMed ID: 29848885 [No Abstract] [Full Text] [Related]
17. Enzyme replacement therapy in an infant with Pompe's disease with severe cardiomyopathy. Tanzer F; Buyukkayhan D; Cansu Mutlu E; Kalender Korkmaz F J Pediatr Endocrinol Metab; 2009 Dec; 22(12):1159-62. PubMed ID: 20333876 [TBL] [Abstract][Full Text] [Related]